Institutional investors purchased a net $1.2 million shares of BGNE during the quarter ended March 2019, and now own 52.46% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRIMECAP MANAGEMENT CO. Bought 322.6 Thousand shares of Beigene Ltd
PICTET ASSET MANAGEMENT SA Bought 232.0 Thousand shares of Beigene Ltd
BLACKROCK FUND ADVISORS Bought 123.2 Thousand shares of Beigene Ltd